kidney cancer, prostate cancer, bladder cancer
Conditions
Interventions
observation group:None
Sponsors
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Adults (>=18 years of age) with suspected or newly diagnosed urologic tumors. 2.Willing and able to provide informed consent for prospective data collection. 3.Obtained sufficient tumor tissue samples to be able to cooperate in completing postoperative follow-up investigations.
Exclusion criteria
Exclusion criteria: 1.Comorbid other malignancies (within 5 years) who have received prior chemotherapy or targeted therapy for malignancy; 2.Women who are pregnant or breastfeeding; 3.Those with other serious heart conditions such as heart failure, heart attack, or severe allergies who cannot tolerate chemotherapy or immunotherapy; 4.Incomplete clinical and imaging data and follow-up information. 5.Presence of contraindications to organoid culture;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy of drug sensitivity results; | — |
Secondary
| Measure | Time frame |
|---|---|
| Differences in survival curves between organoid-sensitive and drug-resistant groups; | — |
Countries
China
Contacts
Public ContactXin Xie
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed